|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2023―Oct―10 |
From De Novo Design to Redesign: Harnessing Computational Protein Design for Understanding SARS-CoV-2 Molecular Mechanisms and Developing Therapeutics |
Aditya K. Padhi, Parismita Kalita, Shweata Maurya, Krishna Mohan Poluri, Timir Tripathi |
2 |
[GO] |
2023―Sep―29 |
Comparative Study of the Mutations Observed in the SARS-CoV-2 RBD Variants of Concern and Their Impact on the Interaction with the ACE2 Protein |
Mariem Ghoula, Audrey Deyawe Kongmeneck, Rita Eid, Anne-Claude Camproux, Gautier Moroy |
3 |
[GO] |
2023―Sep―28 |
Riding the Wave: Unveiling the Conformational Waves from RBD of SARS-CoV-2 Spike Protein to ACE2 |
Nikhil Maroli |
4 |
[GO] |
2023―Sep―27 |
Free Energy Simulations of Receptor-Binding Domain Opening of the SARS-CoV-2 Spike Indicate a Barrierless Transition with Slow Conformational Motions |
Victor Ovchinnikov, Martin Karplus |
5 |
[GO] |
2023―Sep―22 |
Intrinsically Disordered Regions Function as a Cervical Collar to Remotely Regulate the Nodding Dynamics of SARS-CoV-2 Prefusion Spike Heads |
Anushree Sinha, Susmita Roy |
6 |
[GO] |
2023―Jul―31 |
Comparison and Possible Binding Orientations of SARS-CoV-2 Spike N-Terminal Domain for Gangliosides GM3 and GM1 |
Tanushree Das, Chaitali Mukhopadhyay |
7 |
[GO] |
2023―May―17 |
Molecular Insights into the Binding Behavior of Imidazolium Ionic Liquids to the Receptor Binding Domain of the SARS-CoV-2 Spike Protein |
Peng Liu, Yao Li, Yawei Liu, Ju Liu, Kun Dong, Qingzhu Jia |
8 |
[GO] |
2023―May―12 |
Adsorption of SARS-CoV-2 Spike (N501Y) RBD to Human Angiotensin-Converting Enzyme 2 at a Lipid/Water Interface |
Harison Rozak, Satoshi Nihonyanagi, Anton Myalitsin, Subhadip Roy, Mohammed Ahmed, Tahei Tahara, Izabela I. Rzeznicka |
9 |
[GO] |
2023―Mar―13 |
Biophysical Interpretation of Evolutionary Consequences on the SARS-CoV2 Main Protease through Molecular Dynamics Simulations and Network Topology Analysis |
Nuttawat Sawang, Saree Phongphanphanee, Jirasak Wong-ekkabut, Thana Sutthibutpong |
10 |
[GO] |
2023―Feb―24 |
Machine Learning Guided Design of High-Affinity ACE2 Decoys for SARS-CoV-2 Neutralization |
Matthew C. Chan, Kui. K. Chan, Erik Procko, Diwakar Shukla |
11 |
[GO] |
2023―Feb―15 |
Biophysical Correlates of Enhanced Immunogenicity of a Stabilized Variant of the Receptor Binding Domain of SARS-CoV-2 |
Kawkab Kanjo, Gopinath Chattopadhyay, Sameer Kumar Malladi, Randhir Singh, Sowrabha Jayatheertha, Raghavan Varadarajan |
12 |
[GO] |
2023―Jan―23 |
Potential Self-Peptide Inhibitors of the SARS-CoV-2 Main Protease |
Arkadeep Banerjee, Shachi Gosavi |
13 |
[GO] |
2022―Oct―11 |
Computational Design and Experimental Validation of ACE2-Derived Peptides as SARS-CoV-2 Receptor Binding Domain Inhibitors |
Sudeep Sarma, Stephanie M. Herrera, Xingqing Xiao, Gregory A. Hudalla, Carol K. Hall |
14 |
[GO] |
2022―Sep―30 |
Quantifying Mutational Response to Track the Evolution of SARS-CoV-2 Spike Variants: Introducing a Statistical-Mechanics-Guided Machine Learning Method |
Satyam Sangeet, Raju Sarkar, Saswat K. Mohanty, Susmita Roy |
15 |
[GO] |
2022―Sep―06 |
Electrostatic Features for the Receptor Binding Domain of SARS-COV-2 Wildtype and Its Variants. Compass to the Severity of the Future Variants with the Charge-Rule |
Fernando L. Barroso da Silva, Carolina Corrêa Giron, Aatto Laaksonen |
16 |
[GO] |
2022―Jul―14 |
All-Atom Simulations of Human ACE2-Spike Protein RBD Complexes for SARS-CoV-2 and Some of its Variants: Nature of Interactions and Free Energy Diagrams for Dissociation of the Protein Complexes |
Saheb Dutta, Bhavana Panthi, Amalendu Chandra |
17 |
[GO] |
2022―Jul―12 |
Fast Prediction of Binding Affinities of SARS-CoV-2 Spike Protein and Its Mutants with Antibodies through Intermolecular Interaction Modeling-Based Machine Learning |
Alexander H. Williams, Chang-Guo Zhan |
18 |
[GO] |
2022―Jun―23 |
Ionization of D571 Is Coupled with SARS-CoV-2 Spike Up/Down Equilibrium Revealing the pH-Dependent Allosteric Mechanism of Receptor-Binding Domains |
Tong Li, Lan Yu, Jingfang Sun, Jinfeng Liu, Xiao He |
19 |
[GO] |
2022―Jun―20 |
SARS-CoV-2 Omicron Variant Binds to Human Cells More Strongly than the Wild Type: Evidence from Molecular Dynamics Simulation |
Hoang Linh Nguyen, Nguyen Quoc Thai, Phuong H. Nguyen, Mai Suan Li |
20 |
[GO] |
2022―Jun―06 |
Different Binding Modes of SARS-CoV-1 and SARS-CoV-2 Fusion Peptides to Cell Membranes: The Influence of Peptide Helix Length |
Hujun Shen, Zhenhua Wu, Ling Chen |
21 |
[GO] |
2022―May―17 |
Effect of an Amyloidogenic SARS-COV-2 Protein Fragment on α-Synuclein Monomers and Fibrils |
Asis K. Jana, Chance W. Lander, Andrew D. Chesney, Ulrich H. E. Hansmann |
22 |
[GO] |
2022―Apr―11 |
Cocktail of REGN Antibodies Binds More Strongly to SARS-CoV-2 Than Its Components, but the Omicron Variant Reduces Its Neutralizing Ability |
Hung Nguyen, Pham Dang Lan, Daniel A. Nissley, Edward P. O’Brien, Mai Suan Li |
23 |
[GO] |
2022―Mar―22 |
Generalized Methodology for the Quick Prediction of Variant SARS-CoV-2 Spike Protein Binding Affinities with Human Angiotensin-Converting Enzyme II |
Alexander H. Williams, Chang-Guo Zhan |
24 |
[GO] |
2022―Mar―10 |
Combined Computational NMR and Molecular Docking Scrutiny of Potential Natural SARS-CoV-2 Mpro Inhibitors |
Valentin A. Semenov, Leonid B. Krivdin |
25 |
[GO] |
2022―Jan―04 |
Detection of Covid-19 through a Heptanal Biomarker Using Transition Metal Doped Graphene |
Anthony Zhu, Xuan Luo |
26 |
[GO] |
2021―Dec―14 |
In Silico Elucidation of Potent Inhibitors and Rational Drug Design against SARS-CoV-2 Papain-like Protease |
Kamonpan Sanachai, Panupong Mahalapbutr, Vannajan Sanghiran Lee, Thanyada Rungrotmongkol, Supot Hannongbua |
27 |
[GO] |
2021―Sep―27 |
Curious Binding Energy Increase between the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein and Angiotensin-Converting Enzyme 2 Adsorbed on a Silane Monolayer from Molecular Dynamics Simulations |
Solène Lecot, Yann Chevolot, Magali Phaner-Goutorbe, Christelle Yeromonahos |
28 |
[GO] |
2021―Sep―21 |
Bioactive Ag3PO4/Polypropylene Composites for Inactivation of SARS-CoV-2 and Other Important Public Health Pathogens |
Lara K. Ribeiro, Marcelo Assis, Lais R. Lima, Dyovani Coelho, Mariana O. Gonçalves, Robert S. Paiva, et al. (+11) Leonardo N. Moraes, Lauana F. Almeida, Felipe Lipsky, Miguel A. San-Miguel, Lúcia H. Mascaro, Rejane M. T. Grotto, Cristina P. Sousa, Ieda L. V. Rosa, Sandra A. Cruz, Juan Andrés, Elson Longo |
29 |
[GO] |
2021―Aug―09 |
Presence of a SARS-CoV-2 Protein Enhances Amyloid Formation of Serum Amyloid A |
Asis K. Jana, Augustus B. Greenwood, Ulrich H. E. Hansmann |
30 |
[GO] |
2021―Jul―30 |
Role of ATP in the RNA Translocation Mechanism of SARS-CoV-2 NSP13 Helicase |
Ryan Weber, Martin McCullagh |
31 |
[GO] |
2021―Jul―28 |
Accelerating COVID-19 Research Using Molecular Dynamics Simulation |
Aditya K. Padhi, Soumya Lipsa Rath, Timir Tripathi |
32 |
[GO] |
2021―Jul―23 |
Structural Decoding of a Small Molecular Inhibitor on the Binding of SARS-CoV-2 to the ACE 2 Receptor |
Pushpendra Mani Mishra, Chayan Kanti Nandi |
33 |
[GO] |
2021―Jul―13 |
Binding of SARS-CoV-2 Fusion Peptide to Host Endosome and Plasma Membrane |
Stefan L. Schaefer, Hendrik Jung, Gerhard Hummer |
34 |
[GO] |
2021―Jul―06 |
Electrostatic Interactions Explain the Higher Binding Affinity of the CR3022 Antibody for SARS-CoV-2 than the 4A8 Antibody |
Hung Nguyen, Pham Dang Lan, Daniel A. Nissley, Edward P. O’Brien, Mai Suan Li |
35 |
[GO] |
2021―Jun―11 |
Targeting SARS-CoV-2 Receptor Binding Domain with Stapled Peptides: An In Silico Study |
Luana Janaína de Campos, Nicholas Y. Palermo, Martin Conda-Sheridan |
36 |
[GO] |
2021―Jun―10 |
Structural and Dynamical Differences in the Spike Protein RBD in the SARS-CoV-2 Variants B.1.1.7 and B.1.351 |
Nisha Bhattarai, Prabin Baral, Bernard S. Gerstman, Prem P. Chapagain |
37 |
[GO] |
2021―May―12 |
Critical Interactions Between the SARS-CoV-2 Spike Glycoprotein and the Human ACE2 Receptor |
Elhan Taka, Sema Z. Yilmaz, Mert Golcuk, Ceren Kilinc, Umut Aktas, Ahmet Yildiz, Mert Gur |
38 |
[GO] |
2021―Apr―30 |
Integrated Biophysical Modeling of the SARS-CoV-2 Spike Protein Binding and Allosteric Interactions with Antibodies |
Gennady M. Verkhivker, Luisa Di Paola |
39 |
[GO] |
2021―Apr―23 |
Fast Prediction of Binding Affinities of the SARS-CoV-2 Spike Protein Mutant N501Y (UK Variant) with ACE2 and Miniprotein Drug Candidates |
Alexander H. Williams, Chang-Guo Zhan |
40 |
[GO] |
2021―Mar―03 |
An Active Site Inhibitor Induces Conformational Penalties for ACE2 Recognition by the Spike Protein of SARS-CoV-2 |
Billy J. Williams-Noonan, Nevena Todorova, Ketav Kulkarni, Marie-Isabel Aguilar, Irene Yarovsky |
41 |
[GO] |
2021―Jan―15 |
Dynamic Network Modeling of Allosteric Interactions and Communication Pathways in the SARS-CoV-2 Spike Trimer Mutants: Differential Modulation of Conformational Landscapes and Signal Transmission via Cascades of Regulatory Switches |
Gennady M. Verkhivker, Luisa Di Paola |
42 |
[GO] |
2020―Dec―02 |
Remdesivir Strongly Binds to Both RNA-Dependent RNA Polymerase and Main Protease of SARS-CoV-2: Evidence from Molecular Simulations |
Hoang Linh Nguyen, Nguyen Quoc Thai, Duc Toan Truong, Mai Suan Li |
43 |
[GO] |
2020―Nov―17 |
Computational Design of 25-mer Peptide Binders of SARS-CoV-2 |
Thassanai Sitthiyotha, Surasak Chunsrivirot |
44 |
[GO] |
2020―Nov―15 |
Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study |
Padmaja D. Wakchaure, Shibaji Ghosh, Bishwajit Ganguly |
45 |
[GO] |
2020―Nov―11 |
How Alcoholic Disinfectants Affect Coronavirus Model Membranes: Membrane Fluidity, Permeability, and Disintegration |
Hossein Eslami, Shubhadip Das, Tianhang Zhou, Florian Müller-Plathe |
46 |
[GO] |
2020―Oct―28 |
Critical Sequence Hotspots for Binding of Novel Coronavirus to Angiotensin Converter Enzyme as Evaluated by Molecular Simulations |
Mahdi Ghorbani, Bernard R. Brooks, Jeffery B. Klauda |
47 |
[GO] |
2020―Oct―23 |
Antiviral Peptides as Promising Therapeutics against SARS-CoV-2 |
Surid Mohammad Chowdhury, Shafi Ahmad Talukder, Akib Mahmud Khan, Nadia Afrin, Md Ackas Ali, Rajib Islam, et al. (+6) Rimon Parves, Abdulla Al Mamun, Md. Abu Sufian, Md Nayeem Hossain, Mohammed Akhter Hossain, Mohammad A. Halim |
48 |
[GO] |
2020―Jul―29 |
Does SARS-CoV-2 Bind to Human ACE2 Stronger Than SARS-CoV? |
Hoang Linh Nguyen, Pham Dang Lan, Nguyen Quoc Thai, Daniel A. Nissley, Edward P. O'Brien, Mai Suan Li |
49 |
[GO] |
2020―Jun―19 |
Developing a Fully-glycosylated Full-length SARS-CoV-2 Spike Protein Model in a Viral Membrane |
Hyeonuk Woo, Sang-Jun Park, Yeol Kyo Choi, Taeyong Park, Maham Tanveer, Yiwei Cao, et al. (+6) Nathan R. Kern, Jumin Lee, Min Sun Yeom, Tristan Ian Croll, Chaok Seok, Wonpil Im |
50 |
[GO] |
2020―Jun―17 |
Critical Differences Between the Binding Features of the Spike Proteins of SARS-CoV-2 and SARS-CoV |
Chen Bai, Arieh Warshel |
51 |
[GO] |
2020―Jun―10 |
Structural basis of potential binding mechanism of remdesivir to SARS-CoV-2 RNA dependent RNA polymerase |
Leili Zhang, Ruhong Zhou |